Dr. Mahantshetty discusses results of chemo-radiotherapy in cervical cancer

Umesh Mahantshetty discusses the results of a trial of chemo-radiotherapy in patients with cervical cancer, presented at the 2017 International Meeting of the European Society of Gynaecological Oncology. In a trial of patients with stage IIIB squamous cell carcinoma of the uterine cervix, cisplatin chemo-radiotherapy and radiotherapy were compared. An absolute benefit of 8% and 8.5% for disease-free survival and overall survival was observed in the chemo-radiotherapy arm.